Impact of Long-Acting Somatostatin Analogues on Glucose Metabolism in Acromegaly: A Hospital-Based Study.
Ming ShenMeng WangWenqiang HeMin HeNidan QiaoZengyi MaZhao YeQilin ZhangYichao ZhangYeping YangYanjiao CaiYakupujiang ABuDuoReYiMuYun LuBin LuXuefei ShouYongfei WangHongying YeYiming LiShiqi LiYao ZhaoXiaoyun CaoZhaoyun ZhangPublished in: International journal of endocrinology (2018)
The deterioration of glucose metabolism induced by SSA treatment is caused by the less reduction of GH and the more inhibition of insulin secretion, which can be predicted by the baseline BG120 during OGTT.